ARCHIVES

Drugs Available To Investigators Centers to Monitor Them Are Listed

This article is from The Cancer Letter archive.

Vol. 03 No. 36 | September 9, 1977

Download PDF Visit The Full Archive

Related Articles

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

May 1, 1992

ELM Wins ACCC Management Contract Over ORC, Others

February 21, 1992

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

April 4, 2008

ONS Award Winners, Grantees, Announced At Annual Congress

July 27, 1990

Sharfstein To Leave FDA

January 7, 2011